James E. Shmerling, Director at Harvard Apparatus Regenerative Technology, Inc. (HRGN), bought 6,864 shares at $4.35 ($30K) on 2023-08-21, disclosed to the SEC on 2023-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.